Registration Now Open for Advances in Recombinant Protein Technologies Meeting at Astra Zeneca, Alderly Park, 19th & 20th November

29 Jul 2013
Sarah Thomas
Associate Editor

Product news

ELRIG (the European Laboratory Robotics Interest Group) are pleased to announce that registration is now open for its Advances in Recombinant Protein Technologies which this year will focus on redesigned synthetic systems. The 2 day symposium will be held at the Astra Zeneca’s Alderley Park Site in Macclesfield on 19th and 20th November.

The symposium’s plenary speakers include world leading experts including Andreas Plückhtun, Claes Gustafsson, Nicolas Mermod, Pedro Mendes and Randy Kaufman.

Dr Kaufman will be discussing his groundbreaking findings in the area of cell death which have recently been published in Nature Cell Biology. His research reveals specific factors which increase the level of protein synthesis leading to oxidative stress and cell death. His findings suggest that limiting protein synthesis will be therapeutic for diseases caused by protein misfolding in the endoplasmic reticulum.

Dr Sanj Kumar, the newly elected Chairman of ELRIG commented ‘ ELRIG is delighted to present this cutting edge symposium showcasing the latest research and technical innovations in protein technologies. This free networking event will enable scientists and vendors to interact in order to share information and experience.’

‘The symposium also includes an exhibition by instrumentation and service providers who will showcase the latest tools and technologies delivering solutions for redesigned synthetic systems.’

To register to attend, please click on the company website link below.

Links

Tags

ProteomicsProteomics is the systemic bioinformatics study of proteins and amino acids, including their structure, size, function and identification. Tools used in proteomics include chromatography, blotting and gels, protein arrays, mass spectrometry and ELISA and associated analysis software. Analyzers and proteomic systems should be sensitive, high resolution, fast and may be automated for high-throughput.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Protein BiologyThe analysis of protein expression, identity and function is vital for many areas of life science research and drug discovery. Some of the most commonly used techniques in protein analysis include Western blotting, electrophoresis and mass spectrometry.Protein SynthesisRecombinant ProteinsTherapeuticsTherapeutics are treatments designed to alleviate or cure diseases. These include pharmaceuticals, biologics, and gene therapies, which work by targeting specific disease mechanisms. Advances in personalized medicine and biologics offer new hope for patients with conditions that were previously difficult to treat. Browse our peer-reviewed product directory to find therapeutic solutions for various diseases; compare products, check user reviews, and get pricing directly from manufacturers.
Registration Now Open for Advances in Recombinant Protein Technologies Meeting at Astra Zeneca, Alderly Park, 19th & 20th November